Carmen J Allegra Selected Research

Carmen J Allegra Research Topics

Disease

20	Neoplasms (Cancer) 11/2022 - 04/2002
17	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 03/2003
16	Colonic Neoplasms (Colon Cancer) 02/2024 - 04/2002
7	Rectal Neoplasms (Rectal Cancer) 12/2020 - 11/2009
7	Carcinoma (Carcinomatosis) 04/2017 - 04/2002
5	Breast Neoplasms (Breast Cancer) 04/2024 - 08/2003
4	Diarrhea 01/2021 - 06/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 10/2021
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2022 - 07/2014
2	Adenocarcinoma 10/2021 - 04/2016
2	Thrombocytopenia (Thrombopenia) 01/2021 - 10/2019
2	Nausea 01/2021 - 10/2019
2	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2010 - 09/2009
2	Microsatellite Instability 03/2007 - 05/2006
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Neutropenia 01/2021
1	Stomatitis 01/2021
1	Anemia 01/2021
1	Vomiting 01/2021
1	Leukopenia 01/2021
1	Residual Neoplasm 12/2020
1	Pathologic Complete Response 12/2019
1	Dehydration (Water Stress) 10/2019
1	Fatigue 10/2019
1	Disease Progression 01/2014
1	Obesity 02/2012
1	Hepatocellular Carcinoma (Hepatoma) 09/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2011
1	Hemorrhage 07/2009
1	Thrombotic Thrombocytopenic Purpura 09/2001
1	Hemolytic-Uremic Syndrome 09/2001
1	Pancreatitis 09/2001

Drug/Important Bio-Agent (IBA)

17	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 01/2003
14	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2024 - 07/2009
11	Leucovorin (Folinic Acid)FDA Link 02/2024 - 01/2003
9	Biomarkers (Surrogate Marker)IBA 05/2017 - 08/2003
6	ErbB Receptors (EGF Receptor)IBA 05/2017 - 04/2009
6	Bevacizumab (Avastin)FDA Link 04/2017 - 07/2009
5	neratinibIBA 04/2024 - 10/2019
5	Thymidylate SynthaseIBA 07/2014 - 04/2002
4	Cetuximab (Erbitux)FDA Link 12/2022 - 04/2009
4	Sodium Glutamate (Accent)IBA 11/2021 - 12/2014
4	Trastuzumab (Herceptin)FDA Link 01/2020 - 04/2016
3	Capecitabine (Xeloda)FDA Link 01/2021 - 06/2014
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 08/2003
3	Codon (Codons)IBA 04/2017 - 04/2009
3	Monoclonal AntibodiesIBA 02/2016 - 04/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2022 - 01/2011
2	Panitumumab (Vectibix)FDA Link 01/2021 - 04/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 12/2019
2	human ERBB2 proteinIBA 10/2019 - 04/2016
2	Sorafenib (BAY 43-9006)FDA Link 09/2011 - 01/2011
2	Sunitinib (Sutent)FDA Link 09/2011 - 01/2011
2	Biological FactorsIBA 02/2010 - 09/2009
2	Proteins (Proteins, Gene)FDA Link 05/2006 - 03/2003
1	Ado-Trastuzumab EmtansineIBA 04/2024
1	Immune Checkpoint InhibitorsIBA 11/2022
1	tivozanibIBA 11/2022
1	atezolizumabIBA 11/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	DT2216IBA 01/2022
1	snake venom protein C activatorIBA 01/2022
1	sotorasibIBA 01/2022
1	Annexin A5IBA 01/2022
1	src-Family KinasesIBA 10/2021
1	Dasatinib (BMS 354825)FDA Link 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019
1	Hormones (Hormone)IBA 12/2019
1	ElectrolytesIBA 10/2019
1	Transaminases (Aminotransferases)IBA 10/2019
1	pertuzumabIBA 10/2019
1	taxaneIBA 10/2019
1	Calcibiotic Root Canal SealerIBA 05/2017
1	XELOXIBA 03/2016
1	EnzymesIBA 07/2014
1	Angiogenesis InhibitorsIBA 01/2014
1	afliberceptIBA 01/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2014
1	velourIBA 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2011
1	pazopanib FDA Link 01/2011
1	Cytotoxins (Cytolysins)IBA 10/2005
1	Annexin A2 (Annexin II)IBA 08/2003
1	ThymosinIBA 08/2003
1	Biotin (Vitamin H)FDA Link 03/2003
1	AvidinIBA 03/2003
1	thiamine triphosphorate (TTP)IBA 09/2001

Therapy/Procedure

24	Therapeutics 02/2024 - 05/2006
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2003
6	Adjuvant Chemotherapy 01/2021 - 04/2002
4	Neoadjuvant Therapy 01/2018 - 01/2015
2	Immunotherapy 11/2022 - 10/2005
1	Investigational Therapies (Experimental Therapy) 09/2016
1	Radiotherapy 06/2014
1	Chemoradiotherapy 11/2009
1	Adjuvant Chemoradiotherapy 11/2009